Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor-derived DCreg infusion in living donor liver transplantation
NCT03164265Phase 2Completed
- Start
- Aug 2017
- Primary completion
- Jul 2024
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Regulatory Donor-Derived Dendritic Cell in liver transplantation. Started Aug 2017; status: completed.
02
Drugs
Regulatory Donor-Derived Dendritic Cell
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT03164265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03164265.